Skip to content

Clinical trials

Phase 1 Body Weight trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Body Weight Phase: Phase 1 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20151
20211
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Carmot Therapeutics, Inc.1
Corbus Pharmaceuticals Inc.1
Eli Lilly and Company1
MBX Biosciences1
Maxine Mendelson1
National Heart, Lung, and Blood Institute (NHLBI)1
Stony Brook University1
The Cooper Institute1
The University of Texas Health Science Center at San Antonio1
University of Houston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Body Weight11
Overweight4
Obesity3
Cardiovascular Diseases2
Metabolic Diseases2
Nutrition Disorders2
Back Pain1
Chest Pain1
Cystic Fibrosis1
Diabetes Mellitus1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.